XML 16 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Comprehensive Loss - USD ($)
shares in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenues:      
Net product revenue $ 0 $ 0 $ 23,404,000
Collaborative agreements 0 0 33,000
Royalties and other revenue 139,000 298,000 558,000
Total revenues 139,000 298,000 23,995,000
Operating expenses:      
Cost of sales (including finite-lived intangible asset amortization) 0 0 1,929,000
Research and development, including stock-based compensation of $4,253, $4,284 and $6,376 respectively 52,816,000 55,046,000 153,621,000
Selling, general and administrative, including stock-based compensation of $7,267, $6,293 and $6,898, respectively 48,083,000 32,342,000 47,230,000
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 0 0 1,600,000
Total operating expenses 100,899,000 87,388,000 204,380,000
Gain on sale of non-financial assets 0 0 132,585,000
Income (loss) from operations (100,760,000) (87,090,000) (47,800,000)
Recognition of gain or loss on extinguishment 0 0 1,003,000
Interest expense (2,780,000) (802,000) (14,544,000)
Interest and other income, net 1,596,000 134,000 2,767,000
Income tax benefit 0 0 0
Net loss (101,944,000) (87,758,000) (58,574,000)
Other comprehensive loss:      
Unrealized gain (loss) on investments (418,000) (4,000) (90,000)
Comprehensive loss $ (102,362,000) $ (87,762,000) $ (58,664,000)
Earnings Per Share, Basic $ (0.62) $ (0.60) $ (0.53)
Weighted Average Number of Shares Issued, Basic 165,733 145,652 110,841